Vitality Watch

Dossier clinicaltrials trial early 16-jun-2026
Small or early-phase human trial or pilot study

An Effectiveness Evaluation for Pathway to Healthy Aging (Path-HA) Care on Health Status of Older Adults

Key claim: A randomized trial is testing whether a 14-week protocol-driven Pathway to Healthy Aging (Path-HA) care program improves health-related quality of life and functional abilities in community-dwelling older adults at risk of accelerated aging.

Abstract

The goal of this clinical trial is to provide a scientific evaluation on the effects of a protocol-driven Pathway to Healthy Aging (Path-HA) Program on promoting the health-related quality of life and functional abilities of older adults who are at risk of accelerated aging in the community. Participants will be randomized to one of the two study arms: 1) the intervention group to receive a 14-week Path-HA care intervention; and 2) the control group with no Path-HA care intervention.

Why this matters

A randomized trial is testing whether a 14-week protocol-driven Pathway to Healthy Aging (Path-HA) care program improves health-related quality of life and functional abilities in community-dwelling older adults at risk of accelerated aging.

Source

Link

Briefing card

An Effectiveness Evaluation for Pathway to Healthy Aging (Path-HA) Care on Health Status of Older Adults
Stage: trial early · clinicaltrials · 16-jun-2026

A randomized trial is testing whether a 14-week protocol-driven Pathway to Healthy Aging (Path-HA) care program improves health-related quality of life and functional abilities in community-dwelling older adults at risk of accelerated aging.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT06105723

build build 880 · 2bcef25 · 2026-11-18